Abstract
EVIDENCE-BASED ANSWER Combination therapy with an alpha-blocker and dihydrotestosterone (DHT) blocker is superior to either agent alone for reducing clinical progression of BPH and symptom deterioration. Combination therapy is inconsistently better than alpha-blockers for reducing acute urinary retention and in need for invasive therapy, but combination therapy causes a few more adverse events than either monotherapy (SOR: A, 2 RCTs).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
